← 產業報告目錄

Lateral Flow Assays Market by Product (Kits, Readers), Application (STI, HEP, TB, Cardiac Marker, Pregnancy, Drug Abuse, Food Safety), Sample (Blood, Urine, Saliva), Technique (Sandwich, Competitive), End User (Hospitals), and Region - Global Forecast to 2030

出版商 MarketsandMarkets產業別 Medical Devices出版日期 2025-08-14頁數 439報告編號 MD4158

授權報價

Single User Licence$4,950 USD
Multi User Licence$6,650 USD
Corporate User Licence$8,150 USD
Global User Licence$10,000 USD
洽詢購買 申請 Sample

報告摘要

The lateral flow assays market is estimated to grow from USD 8.51 billion in 2025 to USD 12.52 billion by 2030 at a CAGR of 8.0%, during the forecast period. This is due to the high prevalence of infectious diseases worldwide and the subsequent need for testing, rapid growth in the geriatric population, the rising use of home-based lateral flow assay devices, and the growing demand for POC testing, which are the major factors driving the growth of this market. However, inconsistent accuracy compared to other methods and the reluctance of doctors and patients to shift from traditional diagnostics restrain the growth of the lateral flow assays market. “The clinical testing segment of the lateral flow assays market, by application, is estimated to hold the largest position during the forecast period.” The clinical testing segment is the largest application segment in the lateral flow assays market. Based on applications, the lateral flow assays market is segmented into clinical testing, veterinary diagnostics, food safety & environmental testing, and drug development & quality testing. The clinical testing segment accounted for the largest share of the lateral flow assays market in 2024. This trend is projected to continue during the study period. The large share of this application segment can be attributed to the rising prevalence of chronic diseases and infectious diseases worldwide, the growing geriatric population, increasing patient awareness about rapid test options, the growing pressure to reduce healthcare costs, and the increasing demand for patient-centric care. “The hospitals & clinics segment accounted for the largest market share in the lateral flow assays market.” Based on end users, the LFA market is segmented into hospitals & clinics, diagnostic laboratories, home care settings, pharmaceutical & biotechnology companies, and others. The hospitals and clinics segment accounted for the largest market share in 2024. Technological advancements, increasing adoption of point-of-care testing, and the growing inclination toward fast and early diagnosis are driving the growth of the hospitals & clinics segment. “North America segment of the lateral flow assays market, by region, is estimated to account for the largest share during the forecast period.” The global lateral flow assays market is segmented into six major regions: North America, Europe, Asia Pacific, Latin America, the Middle East & Africa, and GCC Countries. North America holds the leading position in this market, driven by advanced healthcare infrastructure, significant healthcare expenditure, and the strong presence of key manufacturers. The increasing aging population, rising prevalence of infectious and chronic diseases, and strong demand for home-use and self-test kits further support market growth in North America. This regional segment is expected to maintain its dominant position throughout the forecast period. A breakdown of the primary participants referred to for this report is provided below: • By Company Type: Tier 1: 40%, Tier 2: 30%, and Tier 3: 35% • By Designation: C Level: 27%, Director Level: 18%, and Others: 55% • By Region: North America: 50%, Europe: 20%, Asia Pacific: 20%, Latin America: 7%, and Middle East & Africa: 3% Note 1: Companies are classified into tiers based on their total revenue. As of 2024, Tier 1 = Greater than USD 10.00 billion, Tier 2 = USD 1.00 billion to USD 10.00 billion, and Tier 3 = Less than USD 1.00 billion. Note 2: C-level primaries include CEOs, CFOs, COOs, and VPs. Note 3: Other designations include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers. The major players operating in the lateral flow assays market are Abbott Laboratories (US), F. Hoffman-La Roche Ltd. (Switzerland), Danaher Corporation (US), Becton, Dickinson and Company (US), QuidelOrtho Corporation (US), Siemens AG (Germany), bioMérieux SA (France), Thermo Fisher Scientific, Inc. (US), Revvity, Inc. (US), Hologic Inc. (US), QIAGEN N.V. (Netherlands), Merck KGaA (Germany), Surmodics, Inc. (US), and OraSure Technologies Inc. (US). Research Coverage This report studies the lateral flow assays market based on product, application, technique, sample type, end user, and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets with respect to their individual growth trends. It forecasts the revenue of the market segments with respect to six major regions (and the respective countries in these regions). Reasons to Buy the Report The report will enable established firms as well as entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to gain a larger market share. Firms purchasing the report could use one or a combination of the strategies mentioned below to strengthen their market presence. This report provides insights on the following points:  Analysis of key drivers (High prevalence of infectious diseases, Rising geriatric population, Growing use of home-based lateral flow assay devices, and Growing demand for POC testing), restraints (Inconsistent results of lateral flow assay tests), opportunities (Evolving applications of lateral flow assays and Rising demand for lateral flow assays in food & beverage industry), challenges (Limited reimbursements for lateral flow assay products and Difficulties in procuring quality raw materials to develop tests).  Market Penetration: Comprehensive information on the product portfolios offered by the top players in the lateral flow assays market  Product Development/Innovation: Detailed insights into the upcoming trends, R&D activities, and product launches in the lateral flow assays market  Market Development: Comprehensive information on lucrative emerging regions  Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the lateral flow assays market  Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players
目錄 Table of Contents
1 INTRODUCTION 41 1.1 STUDY OBJECTIVES 41 1.2 MARKET DEFINITION 41 1.2.1 INCLUSIONS & EXCLUSIONS 42 1.3 MARKET SCOPE 43 1.3.1 MARKETS COVERED 43 1.3.2 YEARS CONSIDERED 44 1.4 CURRENCY CONSIDERED 44 1.5 STAKEHOLDERS 44 1.6 SUMMARY OF CHANGES 45 2 RESEARCH METHODOLOGY 46 2.1 RESEARCH DATA 46 2.1.1 SECONDARY DATA 46 2.1.1.1 Key data from secondary sources 47 2.1.2 PRIMARY DATA 48 2.1.2.1 Primary sources 48 2.1.2.2 Key industry insights 49 2.1.2.3 Key data from primary sources 49 2.1.2.4 Breakdown of primary interviews 50 2.2 MARKET SIZE ESTIMATION 51 2.2.1 BOTTOM-UP APPROACH 51 2.2.1.1 Approach 1: Company revenue estimation approach 52 2.2.1.2 Approach 2: Presentations of companies and primary interviews 52 2.2.1.3 Approach 3: Primary interviews 52 2.2.1.4 Approach 4: Growth Forecast 52 2.2.1.5 CAGR projections 53 2.2.2 TOP-DOWN APPROACH 53 2.3 MARKET BREAKDOWN & DATA TRIANGULATION 54 2.4 RESEARCH ASSUMPTIONS 55 2.4.1 STUDY-RELATED ASSUMPTIONS 55 2.4.2 GROWTH RATE ASSUMPTIONS 55 2.5 RISK ASSESSMENT 56 2.6 RESEARCH LIMITATIONS 56 3 EXECUTIVE SUMMARY 57   4 PREMIUM INSIGHTS 62 4.1 LATERAL FLOW ASSAYS MARKET OVERVIEW 62 4.2 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET, BY APPLICATION AND COUNTRY 63 4.3 LATERAL FLOW ASSAYS MARKET, BY COUNTRY 64 4.4 LATERAL FLOW ASSAYS MARKET: REGIONAL MIX 64 4.5 LATERAL FLOW ASSAYS MARKET: EMERGING ECONOMIES VS. DEVELOPED MARKETS 65 5 MARKET OVERVIEW 66 5.1 INTRODUCTION 66 5.2 MARKET DYNAMICS 66 5.2.1 DRIVERS 66 5.2.1.1 High prevalence of infectious diseases 66 5.2.1.2 Rise in geriatric population 67 5.2.1.3 Growing use of home-based lateral flow assay devices 69 5.2.1.4 Growth in demand for POC testing 69 5.2.2 RESTRAINTS 70 5.2.2.1 Inconsistent results of lateral flow assays 70 5.2.3 OPPORTUNITIES 70 5.2.3.1 Evolving applications of lateral flow assays 70 5.2.3.2 Rise in demand for lateral flow assays in food & beverage industry 71 5.2.4 CHALLENGES 72 5.2.4.1 Limited reimbursements for lateral flow assay products 72 5.2.4.2 Difficulties in procuring quality raw materials to develop tests 72 5.3 TECHNOLOGY ANALYSIS 73 5.3.1 KEY TECHNOLOGIES 73 5.3.1.1 Immunochromatography 73 5.3.2 COMPLEMENTARY TECHNOLOGIES 73 5.3.2.1 Lyophilization (Freeze-drying) Technologies 73 5.3.3 ADJACENT TECHNOLOGIES 73 5.3.3.1 ELISA (ENZYME-LINKED IMMUNOSORBENT ASSAYS) 73 5.4 PORTER’S FIVE FORCES ANALYSIS 74 5.4.1 BARGAINING POWER OF SUPPLIERS 75 5.4.2 BARGAINING POWER OF BUYERS 75 5.4.3 THREAT OF NEW ENTRANTS 75 5.4.4 THREAT OF SUBSTITUTES 76 5.4.5 INTENSITY OF COMPETITIVE RIVALRY 76 5.5 REGULATORY LANDSCAPE 76 5.5.1 REGULATORY ANALYSIS 76 5.5.1.1 North America 76 5.5.1.2 Europe 77 5.5.1.3 Asia Pacific 77 5.5.1.3.1 India 77 5.5.1.3.2 China 78 5.5.1.3.3 Japan 78 5.5.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 78 5.5.2.1 North America 78 5.5.2.2 Europe 79 5.5.2.3 Asia Pacific 79 5.5.2.4 Latin America 80 5.5.2.5 Rest of the world 80 5.6 PATENT ANALYSIS 80 5.7 TRADE ANALYSIS 83 5.7.1 IMPORT DATA (HS CODE 382200) 83 5.7.2 EXPORT DATA (HS CODE 382200) 83 5.8 PRICING ANALYSIS 84 5.8.1 INDICATIVE AVERAGE SELLING PRICE TREND, BY REGION 85 5.9 KEY CONFERENCES AND EVENTS 86 5.10 KEY STAKEHOLDERS AND BUYING CRITERIA 87 5.10.1 KEY STAKEHOLDERS IN BUYING PROCESS 87 5.10.2 BUYING CRITERIA 88 5.11 UNMET NEEDS/END-USER EXPECTATIONS IN LATERAL FLOW ASSAYS MARKET 88 5.12 VALUE CHAIN ANALYSIS 89 5.13 SUPPLY CHAIN ANALYSIS 90 5.14 IMPACT OF AI ON LATERAL FLOW ASSAYS MARKET 91 5.14.1 INTRODUCTION 91 5.14.2 MARKET POTENTIAL OF AI IN LATERAL FLOW ASSAYS MARKET 91 5.14.3 AI USE CASES 92 5.14.4 KEY COMPANIES IMPLEMENTING AI 92 5.14.5 FUTURE OF AI IN LATERAL FLOW ASSAYS MARKET 93 5.15 ECOSYSTEM ANALYSIS 93 5.16 CASE STUDY ANALYSIS 95 5.16.1 QUIDEL LAUNCHED NEW TEST WITH BROADER DETECTION WINDOW 95 5.16.2 ABINGTON OFFERED HIGH-SENSITIVITY TESTS FOR GREATER QUALITY 95 5.16.3 SIEMENS OFFERS HIGH-SENSITIVITY TROPONIN I ASSAY TO RAPIDLY DETECT ACUTE MYOCARDIAL INFARCTION 95 5.17 ADJACENT MARKETS FOR LATERAL FLOW ASSAYS MARKET 96 5.18 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 96 5.19 INVESTMENT AND FUNDING SCENARIO 97 5.20 IMPACT OF US TARIFF REGULATION ON LATERAL FLOW ASSAYS MARKET 97 5.20.1 INTRODUCTION 97 5.20.2 KEY TARIFF RATES 98 5.20.3 PRICE IMPACT ANALYSIS 99 5.20.4 KEY IMPACTS ON COUNTRY/REGION 99 5.20.4.1 North America 99 5.20.4.2 Europe 99 5.20.4.3 Asia Pacific 99 5.20.5 IMPACT ON END-USE INDUSTRIES 100 5.20.5.1 Hospitals and Clinics 100 6 LATERAL FLOW ASSAYS MARKET, BY PRODUCT 101 6.1 INTRODUCTION 102 6.2 KITS & REAGENTS 102 6.2.1 RISE IN DEMAND FOR POC TESTING TO DRIVE MARKET 102 6.3 READERS 106 6.3.1 DIGITAL/HANDHELD READERS 109 6.3.1.1 Technological evolution and demand for accuracy to drive adoption 109 6.3.2 BENCHTOP READERS 111 6.3.2.1 Lower diagnosis cost per patient to drive segment 111 7 LATERAL FLOW ASSAYS MARKET, BY APPLICATION 115 7.1 INTRODUCTION 116 7.2 CLINICAL TESTING 116 7.2.1 INFECTIOUS DISEASE TESTING 119 7.2.1.1 Mosquito-borne diseases 122 7.2.1.1.1 Increase in incidence of dengue and introduction of more reliable test kits to drive market 122 7.2.1.2 Influenza 126 7.2.1.2.1 Rise in prevalence of influenza globally to boost market growth, despite lower sensitivity of lateral flow assays 126 7.2.1.3 Sexually transmitted infections 129 7.2.1.3.1 HIV 132 7.2.1.3.1.1 Growing need for early detection and awareness of HIV POC testing to drive market 132 7.2.1.3.2 HPV 135 7.2.1.3.2.1 Rapid HPV diagnostics and real-time PCR, covering broad range of genotypes, coupled with higher incidence of cervical cancer to drive segment 135 7.2.1.3.3 Chlamydia 138 7.2.1.3.3.1 Greater viability of advanced techniques to drive market 138 7.2.1.3.4 Gonorrhea 141 7.2.1.3.4.1 Rising incidence of gonorrhea and antimicrobial resistance to augment growth 141 7.2.1.3.5 Syphilis 144 7.2.1.3.5.1 Need for early and accessible diagnosis to fuel growth 144 7.2.1.3.6 Other sexually transmitted infections 147 7.2.1.4 Hepatitis 150 7.2.1.4.1 Nucleic acid hybridization-based LFAs to show strong potential in hepatitis testing 150 7.2.1.5 Tuberculosis 152 7.2.1.5.1 Rise in prevalence and growing focus on early diagnosis and treatment to propel market 152 7.2.1.6 Other infectious diseases 155 7.2.2 CARDIAC MARKER TESTING 157 7.2.2.1 Troponin I & T 160 7.2.2.1.1 Introduction of high-sensitivity troponin assays to support market growth 160 7.2.2.2 CK-MB 163 7.2.2.2.1 Growing applications of lateral flow tests in acute myocardial injuries to drive market 163 7.2.2.3 BNP & NT-proBNP 166 7.2.2.3.1 Increase in demand for cardiac biomarker tests to detect heart stress and damage to support growth 166 7.2.2.4 Myoglobin 168 7.2.2.4.1 Availability of new high-sensitivity cardiac troponin assays to restrict market growth 168 7.2.2.5 D-Dimer 170 7.2.2.5.1 Rising incidence of CVDs to drive market for D-dimer tests 170 7.2.2.6 Other cardiac marker testing 172 7.2.3 PREGNANCY & FERTILITY TESTING 175 7.2.3.1 Pregnancy testing 178 7.2.3.1.1 Pregnancy testing to hold larger market share but register slower growth 178 7.2.3.2 Fertility testing 181 7.2.3.2.1 Rise in infertility rates to drive demand for POC fertility testing kits 181 7.2.4 CHOLESTEROL/LIPID TESTING 183 7.2.4.1 Lifestyle changes, cardiovascular disorder incidence to drive segment 183 7.2.5 DRUGS-OF-ABUSE TESTING 186 7.2.5.1 Technological advancements and rising focus on workplace drug testing to drive market 186 7.2.6 OTHER CLINICAL TESTS 189 7.3 VETERINARY DIAGNOSTICS 192 7.3.1 INFECTIOUS DISEASE OUTBREAKS AND TESTS AVAILABLE FOR DIFFERENT SPECIES TO DRIVE FRAGMENTED MARKET 192 7.4 FOOD SAFETY & ENVIRONMENT TESTING 194 7.4.1 HIGH SENSITIVITY AND EASE OF USE TO BOOST DEMAND FOR ASSAYS TO CLEAR FOODS FOR MARKET AVAILABILITY 194 7.5 DRUG DEVELOPMENT & QUALITY TESTING 196 7.5.1 GREATER FOCUS ON PRODUCT SAFETY AND QUALITY ASSURANCE TO SUPPORT MARKET GROWTH 196   8 LATERAL FLOW ASSAYS MARKET, BY TECHNIQUE 200 8.1 INTRODUCTION 201 8.2 SANDWICH ASSAYS 201 8.2.1 WIDE RANGE OF APPLICATIONS IN CLINICAL TESTING TO SUPPORT MARKET GROWTH 201 8.3 COMPETITIVE ASSAYS 204 8.3.1 REDUCED SELECTIVITY AND SENSITIVITY COMPARED TO SANDWICH ASSAYS TO HAMPER GROWTH 204 8.4 MULTIPLEX DETECTION ASSAYS 206 8.4.1 HIGHER ADOPTION OF MULTI-ANALYTE ASSAYS AMONG CLINICIANS TO FUEL MARKET 206 9 LATERAL FLOW ASSAYS MARKET, BY SAMPLE TYPE 210 9.1 INTRODUCTION 211 9.2 BLOOD SAMPLES 211 9.2.1 SIGNIFICANT USE OF BLOOD SAMPLES FOR INFECTIOUS DISEASE TESTING TO DRIVE MARKET 211 9.3 URINE SAMPLES 214 9.3.1 GROWING USE OF URINE SAMPLES FOR PREGNANCY AND DRUGS-OF-ABUSE TESTING TO DRIVE MARKET 214 9.4 SALIVA SAMPLES 216 9.4.1 EASY AND LOW-COST COLLECTION, TRANSPORT, AND ANALYSIS OF SALIVA SAMPLES TO SUPPORT ADOPTION 216 9.5 OTHER SAMPLES 218 10 LATERAL FLOW ASSAYS MARKET, BY END USER 221 10.1 INTRODUCTION 222 10.2 HOSPITALS & CLINICS 222 10.2.1 HIGH DEMAND FOR DIAGNOSTICS ACROSS LARGE POOLS OF PATIENTS IN HOSPITALS TO DRIVE MARKET 222 10.3 HOME CARE SETTINGS 225 10.3.1 GROWING ACCEPTANCE OF REMOTE MONITORING TO PROPEL MARKET 225 10.4 DIAGNOSTIC LABORATORIES 227 10.4.1 LABORATORY TESTING LARGELY PREFERRED OVER PROFESSIONAL SETTINGS FOR URINE AND BLOOD TESTING 227 10.5 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 230 10.5.1 INCREASE IN FOCUS ON PRODUCT SAFETY TO DRIVE ADOPTION OF LATERAL FLOW ASSAYS 230 10.6 OTHER END USERS 232   11 LATERAL FLOW ASSAYS MARKET, BY REGION 236 11.1 INTRODUCTION 237 11.2 NORTH AMERICA 238 11.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 238 11.2.2 US 244 11.2.2.1 Large patient base to drive market growth 244 11.2.3 CANADA 249 11.2.3.1 Availability of research funding and implementation of favorable government initiatives to drive market 249 11.3 EUROPE 254 11.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 254 11.3.2 GERMANY 259 11.3.2.1 Well-developed healthcare system and rise in geriatric population to fuel growth 259 11.3.3 UK 264 11.3.3.1 Growth in incidence of chronic conditions to propel market growth 264 11.3.4 FRANCE 269 11.3.4.1 High prevalence of age-related chronic diseases and infectious diseases to drive market 269 11.3.5 ITALY 274 11.3.5.1 Growth in initiatives toward decentralization of medical services to support market growth 274 11.3.6 SPAIN 278 11.3.6.1 Aging population and strong healthcare infrastructure to drive market 278 11.3.7 REST OF EUROPE 283 11.4 ASIA PACIFIC 288 11.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 288 11.4.2 JAPAN 294 11.4.2.1 Growing elderly population and well-developed healthcare system to drive market 294 11.4.3 CHINA 299 11.4.3.1 Modernized healthcare system to drive market 299 11.4.4 INDIA 304 11.4.4.1 Growth in healthcare concerns and rise in income levels to propel market growth, despite lack of reimbursement and insurance coverage for lateral flow assay products 304 11.4.5 AUSTRALIA 309 11.4.5.1 Rise in prevalence of infectious disease and healthcare expenditure to support growth 309 11.4.6 SOUTH KOREA 314 11.4.6.1 Growth in healthcare infrastructure to drive market 314 11.4.7 REST OF ASIA PACIFIC 319   11.5 LATIN AMERICA 324 11.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 324 11.5.2 BRAZIL 329 11.5.2.1 High private healthcare expenditure and rise in geriatric population to drive market 329 11.5.3 MEXICO 334 11.5.3.1 Increase in demand for advanced medical equipment to drive market 334 11.5.4 ARGENTINA 339 11.5.4.1 Availability of health insurance to favor market growth 339 11.5.5 REST OF LATIN AMERICA 343 11.6 MIDDLE EAST & AFRICA 348 11.7 GCC COUNTRIES 353 11.7.1 RISE IN DEMAND FOR RAPID AND COST-EFFECTIVE DIAGNOSTICS TO DRIVE MARKET 353 12 COMPETITIVE LANDSCAPE 359 12.1 INTRODUCTION 359 12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 359 12.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN LATERAL FLOW ASSAYS MARKET 360 12.3 REVENUE ANALYSIS, 2020-2024 361 12.4 MARKET SHARE ANALYSIS, 2024 362 12.5 COMPANY VALUATION AND FINANCIAL METRICS 364 12.6 BRAND/PRODUCT COMPARISON 365 12.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 366 12.7.1 STARS 366 12.7.2 EMERGING LEADERS 366 12.7.3 PERVASIVE PLAYERS 366 12.7.4 PARTICIPANTS 366 12.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024 368 12.7.5.1 Company footprint 368 12.7.5.2 Regional Footprint 369 12.7.5.3 Product Footprint 370 12.7.5.4 Technique Footprint 371 12.7.5.5 Application Footprint 372 12.7.5.6 Sample type Footprint 373 12.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024 373 12.8.1 PROGRESSIVE COMPANIES 373 12.8.2 RESPONSIVE COMPANIES 374 12.8.3 DYNAMIC COMPANIES 374 12.8.4 STARTING BLOCKS 374   12.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024 375 12.8.5.1 Detailed list of key startup/SME players 375 12.8.5.2 Competitive benchmarking of key startups/SMEs 375 12.9 COMPETITIVE SCENARIO 376 12.9.1 PRODUCT LAUNCHES 376 12.9.2 DEALS 376 12.9.3 EXPANSIONS 377 13 COMPANY PROFILES 378 13.1 KEY PLAYERS 378 13.1.1 ABBOTT LABORATORIES 378 13.1.1.1 Business overview 378 13.1.1.2 Products offered 379 13.1.1.3 Recent developments 383 13.1.1.3.1 Product launches & approvals 383 13.1.1.4 MnM view 383 13.1.1.4.1 Right to win 383 13.1.1.4.2 Strategic choices 383 13.1.1.4.3 Weaknesses and competitive threats 383 13.1.2 F. HOFFMANN-LA ROCHE LTD. 384 13.1.2.1 Business overview 384 13.1.2.2 Products offered 385 13.1.2.3 MnM view 386 13.1.2.3.1 Right to win 386 13.1.2.3.2 Strategic choices 386 13.1.2.3.3 Weaknesses and competitive threats 386 13.1.3 DANAHER CORPORATION 387 13.1.3.1 Business overview 387 13.1.3.2 Products offered 388 13.1.3.3 MnM view 389 13.1.3.3.1 Right to win 389 13.1.3.3.2 Strategic choices 389 13.1.3.3.3 Weaknesses and competitive threats 389 13.1.4 QUIDELORTHOORTHO CORPORATION 390 13.1.4.1 Business overview 390 13.1.4.2 Products offered 391 13.1.4.3 Recent developments 392 13.1.4.3.1 Deals 392   13.1.5 SIEMENS AG 393 13.1.5.1 Business overview 393 13.1.5.2 Products offered 395 13.1.6 BECTON, DICKINSON AND COMPANY 396 13.1.6.1 Business overview 396 13.1.6.2 Products offered 398 13.1.7 BIOMÉRIEUX SA 399 13.1.7.1 Business overview 399 13.1.7.2 Products offered 400 13.1.7.3 Recent developments 401 13.1.7.3.1 Deals 401 13.1.8 THERMO FISHER SCIENTIFIC INC. 402 13.1.8.1 Business overview 402 13.1.8.2 Products offered 403 13.1.9 REVVITY, INC. 405 13.1.9.1 Business overview 405 13.1.9.2 Products offered 406 13.1.10 QIAGEN N.V. 407 13.1.10.1 Business overview 407 13.1.10.2 Products offered 408 13.1.11 MERCK KGAA 409 13.1.11.1 Business overview 409 13.1.11.2 Products offered 410 13.1.11.3 Recent developments 410 13.1.11.3.1 Expansions 410 13.1.12 HOLOGIC, INC. 411 13.1.12.1 Business overview 411 13.1.12.2 Products offered 412 13.1.12.3 Recent developments 413 13.1.12.3.1 Deals 413 13.1.13 SURMODICS, INC. 414 13.1.13.1 Business overview 414 13.1.13.2 Products offered 416 13.1.13.3 Recent developments 416 13.1.13.3.1 Deals 416 13.1.14 ORASURE TECHNOLOGIES 417 13.1.14.1 Business overview 417 13.1.14.2 Products offered 418   13.2 OTHER PLAYERS 419 13.2.1 CHEMBIO DIAGNOSTICS INC. 419 13.2.2 DCN DIAGNOSTICS 420 13.2.3 POLYSCIENCES INC. 421 13.2.4 ABINGDON HEALTH 422 13.2.5 ORANOXIS INC. 423 13.2.6 AESKU.GROUP GMBH 424 13.2.7 BIO GROUP MEDICAL SYSTEM S.R.L 425 13.2.8 PHARMACT GMBH 426 13.2.9 XIAMEN BIOTIME BIOTECHNOLOGY CO., LTD. 427 13.2.10 BIOPANDA REAGENTS LTD 428 13.2.11 ARTRON LABORATORIES INC. 429 14 APPENDIX 430 14.1 DISCUSSION GUIDE 430 14.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 435 14.3 CUSTOMIZATION OPTIONS 437 14.4 RELATED REPORTS 437 14.5 AUTHOR DETAILS 438
圖表清單 List of Tables & Figures
TABLE 1 LATERAL FLOW ASSAYS MARKET: INCLUSIONS & EXCLUSIONS 42 TABLE 2 KEY DATA FROM PRIMARY SOURCES 49 TABLE 3 LATERAL FLOW ASSAYS MARKET: RISK ASSESSMENT 56 TABLE 4 REAL INCIDENCE OF HIV, 2023 (MILLION PEOPLE) 67 TABLE 5 POPULATION AGES 65 AND ABOVE (% OF TOTAL POPULATION), 2023 68 TABLE 6 LIST OF COMMERCIALLY AVAILABLE SALIVA LFA PRODUCTS 71 TABLE 7 LATERAL FLOW ASSAYS MARKET: PORTER’S FIVE FORCES ANALYSIS 75 TABLE 8 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 78 TABLE 9 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 79 TABLE 10 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 79 TABLE 11 LATIN AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 80 TABLE 12 ROW: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 80 TABLE 13 LATERAL FLOW ASSAYS MARKET: INNOVATIONS AND PATENT REGISTRATIONS, 2023–2025 82 TABLE 14 IMPORT DATA (HS CODE 382200), BY COUNTRY, 2020–2024 (USD MILLION) 83 TABLE 15 EXPORT DATA (HS CODE 382200), BY COUNTRY, 2020–2024 (USD MILLION) 83 TABLE 16 AVERAGE SELLING PRICE OF LATERAL FLOW ASSAYS (KITS & REAGENTS), BY COMPANY, 2023–2025 (USD) 84 TABLE 17 AVERAGE SELLING PRICE OF LATERAL FLOW ASSAYS (KITS & REAGENTS), BY APPLICATION, 2023–2025 (USD) 84 TABLE 18 INDICATIVE AVERAGE SELLING PRICE OF LATERAL FLOW ANALYZERS, BY REGION, 2023 VS. 2024 85 TABLE 19 LATERAL FLOW ASSAYS MARKET: KEY CONFERENCES AND EVENTS, JUNE 2025–DECEMBER 2026 86 TABLE 20 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE APPLICATIONS 87 TABLE 21 KEY BUYING CRITERIA FOR TOP THREE APPLICATIONS 88 TABLE 22 UNMET NEEDS/END-USER EXPECTATIONS IN LATERAL FLOW ASSAYS MARKET 88 TABLE 23 LATERAL FLOW ASSAYS MARKET: ROLE OF COMPANIES IN ECOSYSTEM 94 TABLE 24 US ADJUSTED RECIPROCAL TARIFF RATES 98 TABLE 25 LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 102 TABLE 26 LATERAL FLOW ASSAYS MARKET FOR KITS & REAGENTS, BY REGION, 2023–2030 (USD MILLION) 103 TABLE 27 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR KITS & REAGENTS, BY COUNTRY, 2023–2030 (USD MILLION) 103 TABLE 28 EUROPE: LATERAL FLOW ASSAYS MARKET FOR KITS & REAGENTS, BY COUNTRY, 2023–2030 (USD MILLION) 103 TABLE 29 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR KITS & REAGENTS, BY COUNTRY, 2023–2030 (USD MILLION) 104 TABLE 30 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR KITS & REAGENTS, BY COUNTRY, 2023–2030 (USD MILLION) 104 TABLE 31 INDICATIVE LIST OF LATERAL FLOW ASSAY KITS & REAGENTS: WITH AND WITHOUT ANALYZERS 105 TABLE 32 LATERAL FLOW READERS OFFERED, BY COMPANY 106 TABLE 33 LATERAL FLOW ASSAYS MARKET, FOR READERS, BY TYPE, 2023–2030 (USD MILLION) 107 TABLE 34 LATERAL FLOW ASSAYS MARKET FOR READERS, BY REGION, 2023–2030 (USD MILLION) 107 TABLE 35 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR READERS, BY COUNTRY, 2023–2030 (USD MILLION) 107 TABLE 36 EUROPE: LATERAL FLOW ASSAYS MARKET FOR READERS, BY COUNTRY, 2023–2030 (USD MILLION) 108 TABLE 37 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR READERS, BY COUNTRY, 2023–2030 (USD MILLION) 108 TABLE 38 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR READERS, BY COUNTRY, 2023–2030 (USD MILLION) 109 TABLE 39 LATERAL FLOW ASSAYS MARKET FOR DIGITAL/HANDHELD READERS, BY REGION, 2023–2030 (USD MILLION) 110 TABLE 40 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR DIGITAL/HANDHELD READERS, BY COUNTRY, 2023–2030 (USD MILLION) 110 TABLE 41 EUROPE: LATERAL FLOW ASSAYS MARKET FOR DIGITAL/HANDHELD READERS, BY COUNTRY, 2023–2030 (USD MILLION) 110 TABLE 42 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR DIGITAL/HANDHELD READERS, BY COUNTRY, 2023–2030 (USD MILLION) 111 TABLE 43 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR DIGITAL/HANDHELD READERS, BY COUNTRY, 2023–2030 (USD MILLION) 111 TABLE 44 LATERAL FLOW ASSAYS MARKET FOR BENCHTOP READERS, BY REGION, 2023–2030 (USD MILLION) 112 TABLE 45 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR BENCHTOP READERS, BY COUNTRY, 2023–2030 (USD MILLION) 112 TABLE 46 EUROPE: LATERAL FLOW ASSAYS MARKET FOR BENCHTOP READERS, BY COUNTRY, 2023–2030 (USD MILLION) 113 TABLE 47 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR BENCHTOP READERS, BY COUNTRY, 2023–2030 (USD MILLION) 113 TABLE 48 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR BENCHTOP READERS, BY COUNTRY, 2023–2030 (USD MILLION) 114 TABLE 49 LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 116 TABLE 50 LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2023–2030 (USD MILLION) 117 TABLE 51 LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY REGION, 2023–2030 (USD MILLION) 117 TABLE 52 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY COUNTRY, 2023–2030 (USD MILLION) 118 TABLE 53 EUROPE: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY COUNTRY, 2023–2030 (USD MILLION) 118 TABLE 54 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY COUNTRY, 2023–2030 (USD MILLION) 119 TABLE 55 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY COUNTRY, 2023–2030 (USD MILLION) 119 TABLE 56 LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2023–2030 (USD MILLION) 120 TABLE 57 LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY REGION, 2023–2030 (USD MILLION) 120 TABLE 58 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY COUNTRY, 2023–2030 (USD MILLION) 121 TABLE 59 EUROPE: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY COUNTRY, 2023–2030 (USD MILLION) 121 TABLE 60 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY COUNTRY, 2023–2030 (USD MILLION) 122 TABLE 61 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY COUNTRY, 2023–2030 (USD MILLION) 122 TABLE 62 MAJOR PRODUCTS: DENGUE TESTING 123 TABLE 63 LATERAL FLOW ASSAYS MARKET FOR MOSQUITO-BORNE DISEASES, BY REGION, 2023–2030 (USD MILLION) 124 TABLE 64 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR MOSQUITO-BORNE DISEASES, BY COUNTRY, 2023–2030 (USD MILLION) 124 TABLE 65 EUROPE: LATERAL FLOW ASSAYS MARKET FOR MOSQUITO-BORNE DISEASES, BY COUNTRY, 2023–2030 (USD MILLION) 125 TABLE 66 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR MOSQUITO-BORNE DISEASES, BY COUNTRY, 2023–2030 (USD MILLION) 125 TABLE 67 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR MOSQUITO-BORNE DISEASES, BY COUNTRY, 2023–2030 (USD MILLION) 126 TABLE 68 LATERAL FLOW ASSAYS MARKET FOR INFLUENZA, BY REGION, 2023–2030 (USD MILLION) 127 TABLE 69 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR INFLUENZA, BY COUNTRY, 2023–2030 (USD MILLION) 127 TABLE 70 EUROPE: LATERAL FLOW ASSAYS MARKET FOR INFLUENZA, BY COUNTRY, 2023–2030 (USD MILLION) 128 TABLE 71 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR INFLUENZA, BY COUNTRY, 2023–2030 (USD MILLION) 128 TABLE 72 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR INFLUENZA, BY COUNTRY, 2023–2030 (USD MILLION) 129 TABLE 73 LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2023–2030 (USD MILLION) 130 TABLE 74 LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY REGION, 2023–2030 (USD MILLION) 130 TABLE 75 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY COUNTRY, 2023–2030 (USD MILLION) 131 TABLE 76 EUROPE: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY COUNTRY, 2023–2030 (USD MILLION) 131 TABLE 77 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY COUNTRY, 2023–2030 (USD MILLION) 132 TABLE 78 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY COUNTRY, 2023–2030 (USD MILLION) 132 TABLE 79 LATERAL FLOW ASSAYS MARKET FOR HIV, BY REGION, 2023–2030 (USD MILLION) 133 TABLE 80 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR HIV, BY COUNTRY, 2023–2030 (USD MILLION) 133 TABLE 81 EUROPE: LATERAL FLOW ASSAYS MARKET FOR HIV, BY COUNTRY, 2023–2030 (USD MILLION) 134 TABLE 82 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR HIV, BY COUNTRY, 2023–2030 (USD MILLION) 134 TABLE 83 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR HIV, BY COUNTRY, 2023–2030 (USD MILLION) 135 TABLE 84 LATERAL FLOW ASSAYS MARKET FOR HPV, BY REGION, 2023–2030 (USD MILLION) 136 TABLE 85 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR HPV, BY COUNTRY, 2023–2030 (USD MILLION) 136 TABLE 86 EUROPE: LATERAL FLOW ASSAYS MARKET FOR HPV, BY COUNTRY, 2023–2030 (USD MILLION) 137 TABLE 87 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR HPV, BY COUNTRY, 2023–2030 (USD MILLION) 137 TABLE 88 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR HPV, BY COUNTRY, 2023–2030 (USD MILLION) 138 TABLE 89 KEY CHLAMYDIA TESTING PRODUCTS AVAILABLE WORLDWIDE 139 TABLE 90 LATERAL FLOW ASSAYS MARKET FOR CHLAMYDIA, BY REGION, 2023–2030 (USD MILLION) 139 TABLE 91 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR CHLAMYDIA, BY COUNTRY, 2023–2030 (USD MILLION) 139 TABLE 92 EUROPE: LATERAL FLOW ASSAYS MARKET FOR CHLAMYDIA, BY COUNTRY, 2023–2030 (USD MILLION) 140 TABLE 93 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR CHLAMYDIA, BY COUNTRY, 2023–2030 (USD MILLION) 140 TABLE 94 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR CHLAMYDIA, BY COUNTRY, 2023–2030 (USD MILLION) 141 TABLE 95 LATERAL FLOW ASSAYS MARKET FOR GONORRHEA, BY REGION, 2023–2030 (USD MILLION) 142 TABLE 96 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR GONORRHEA, BY COUNTRY, 2023–2030 (USD MILLION) 142 TABLE 97 EUROPE: LATERAL FLOW ASSAYS MARKET FOR GONORRHEA, BY COUNTRY, 2023–2030 (USD MILLION) 143 TABLE 98 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR GONORRHEA, BY COUNTRY, 2023–2030 (USD MILLION) 143 TABLE 99 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR GONORRHEA, BY COUNTRY, 2023–2030 (USD MILLION) 144 TABLE 100 LATERAL FLOW ASSAYS MARKET FOR SYPHILIS, BY REGION, 2023–2030 (USD MILLION) 145 TABLE 101 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR SYPHILIS, BY COUNTRY, 2023–2030 (USD MILLION) 145 TABLE 102 EUROPE: LATERAL FLOW ASSAYS MARKET FOR SYPHILIS, BY COUNTRY, 2023–2030 (USD MILLION) 146 TABLE 103 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR SYPHILIS, BY COUNTRY, 2023–2030 (USD MILLION) 146 TABLE 104 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR SYPHILIS, BY COUNTRY, 2023–2030 (USD MILLION) 147 TABLE 105 LATERAL FLOW ASSAYS MARKET FOR OTHER SEXUALLY TRANSMITTED INFECTIONS, BY REGION, 2023–2030 (USD MILLION) 148 TABLE 106 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR OTHER SEXUALLY TRANSMITTED INFECTIONS, BY COUNTRY, 2023–2030 (USD MILLION) 148 TABLE 107 EUROPE: LATERAL FLOW ASSAYS MARKET FOR OTHER SEXUALLY TRANSMITTED INFECTIONS, BY COUNTRY, 2023–2030 (USD MILLION) 149   TABLE 108 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR OTHER SEXUALLY TRANSMITTED INFECTIONS, BY COUNTRY, 2023–2030 (USD MILLION) 149 TABLE 109 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR OTHER SEXUALLY TRANSMITTED INFECTIONS, BY COUNTRY, 2023–2030 (USD MILLION) 150 TABLE 110 LATERAL FLOW ASSAYS MARKET FOR HEPATITIS, BY REGION, 2023–2030 (USD MILLION) 151 TABLE 111 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR HEPATITIS, BY COUNTRY, 2023–2030 (USD MILLION) 151 TABLE 112 EUROPE: LATERAL FLOW ASSAYS MARKET FOR HEPATITIS, BY COUNTRY, 2023–2030 (USD MILLION) 151 TABLE 113 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR HEPATITIS, BY COUNTRY, 2023–2030 (USD MILLION) 152 TABLE 114 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR HEPATITIS, BY COUNTRY, 2023–2030 (USD MILLION) 152 TABLE 115 GLOBAL NUMBER OF NEWLY DIAGNOSED TB CASES, 2023–2030 (MILLION) 153 TABLE 116 LATERAL FLOW ASSAYS MARKET FOR TUBERCULOSIS, BY REGION, 2023–2030 (USD MILLION) 153 TABLE 117 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR TUBERCULOSIS, BY COUNTRY, 2023–2030 (USD MILLION) 153 TABLE 118 EUROPE: LATERAL FLOW ASSAYS MARKET FOR TUBERCULOSIS, BY COUNTRY, 2023–2030 (USD MILLION) 154 TABLE 119 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR TUBERCULOSIS, BY COUNTRY, 2023–2030 (USD MILLION) 154 TABLE 120 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR TUBERCULOSIS, BY COUNTRY, 2023–2030 (USD MILLION) 155 TABLE 121 LATERAL FLOW ASSAYS MARKET FOR OTHER INFECTIOUS DISEASES, BY REGION, 2023–2030 (USD MILLION) 155 TABLE 122 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR OTHER INFECTIOUS DISEASES, BY COUNTRY, 2023–2030 (USD MILLION) 156 TABLE 123 EUROPE: LATERAL FLOW ASSAYS MARKET FOR OTHER INFECTIOUS DISEASES, BY COUNTRY, 2023–2030 (USD MILLION) 156 TABLE 124 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR OTHER INFECTIOUS DISEASES, BY COUNTRY, 2023–2030 (USD MILLION) 157 TABLE 125 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR OTHER INFECTIOUS DISEASES, BY COUNTRY, 2023–2030 (USD MILLION) 157 TABLE 126 LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2023–2030 (USD MILLION) 158 TABLE 127 LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY REGION, 2023–2030 (USD MILLION) 159 TABLE 128 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY COUNTRY, 2023–2030 (USD MILLION) 159 TABLE 129 EUROPE: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY COUNTRY, 2023–2030 (USD MILLION) 159 TABLE 130 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY COUNTRY, 2023–2030 (USD MILLION) 160 TABLE 131 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY COUNTRY, 2023–2030 (USD MILLION) 160 TABLE 132 LATERAL FLOW ASSAYS MARKET FOR TROPONIN I & T TESTING, BY REGION, 2023–2030 (USD MILLION) 161   TABLE 133 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR TROPONIN I & T TESTING, BY COUNTRY, 2023–2030 (USD MILLION) 161 TABLE 134 EUROPE: LATERAL FLOW ASSAYS MARKET FOR TROPONIN I & T TESTING, BY COUNTRY, 2023–2030 (USD MILLION) 162 TABLE 135 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR TROPONIN I & T TESTING, BY COUNTRY, 2023–2030 (USD MILLION) 162 TABLE 136 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR TROPONIN I & T TESTING, BY COUNTRY, 2023–2030 (USD MILLION) 163 TABLE 137 LATERAL FLOW ASSAYS MARKET FOR CK-MB TESTING, BY REGION, 2023–2030 (USD MILLION) 164 TABLE 138 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR CK-MB TESTING, BY COUNTRY, 2023–2030 (USD MILLION) 164 TABLE 139 EUROPE: LATERAL FLOW ASSAYS MARKET FOR CK-MB TESTING, BY COUNTRY, 2023–2030 (USD MILLION) 164 TABLE 140 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR CK-MB TESTING, BY COUNTRY, 2023–2030 (USD MILLION) 165 TABLE 141 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR CK-MB TESTING, BY COUNTRY, 2023–2030 (USD MILLION) 165 TABLE 142 LATERAL FLOW ASSAYS MARKET FOR BNP & NT-PROBNP TESTING, BY REGION, 2023–2030 (USD MILLION) 166 TABLE 143 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR BNP & NT-PROBNP TESTING, BY COUNTRY, 2023–2030 (USD MILLION) 166 TABLE 144 EUROPE: LATERAL FLOW ASSAYS MARKET FOR BNP & NT-PROBNP TESTING, BY COUNTRY, 2023–2030 (USD MILLION) 167 TABLE 145 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR BNP & NT-PROBNP TESTING, BY COUNTRY, 2023–2030 (USD MILLION) 167 TABLE 146 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR BNP & NT-PROBNP TESTING, BY COUNTRY, 2023–2030 (USD MILLION) 168 TABLE 147 LATERAL FLOW ASSAYS MARKET FOR MYOGLOBIN TESTING, BY REGION, 2023–2030 (USD MILLION) 169 TABLE 148 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR MYOGLOBIN TESTING, BY COUNTRY, 2023–2030 (USD MILLION) 169 TABLE 149 EUROPE: LATERAL FLOW ASSAYS MARKET FOR MYOGLOBIN TESTING, BY COUNTRY, 2023–2030 (USD MILLION) 169 TABLE 150 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR MYOGLOBIN TESTING, BY COUNTRY, 2023–2030 (USD MILLION) 170 TABLE 151 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR MYOGLOBIN TESTING, BY COUNTRY, 2023–2030 (USD MILLION) 170 TABLE 152 LATERAL FLOW ASSAYS MARKET FOR D-DIMER TESTING, BY REGION, 2023–2030 (USD MILLION) 171 TABLE 153 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR D-DIMER TESTING, BY COUNTRY, 2023–2030 (USD MILLION) 171 TABLE 154 EUROPE: LATERAL FLOW ASSAYS MARKET FOR D-DIMER TESTING, BY COUNTRY, 2023–2030 (USD MILLION) 171 TABLE 155 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR D-DIMER TESTING, BY COUNTRY, 2023–2030 (USD MILLION) 172 TABLE 156 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR D-DIMER TESTING, BY COUNTRY, 2023–2030 (USD MILLION) 172 TABLE 157 LATERAL FLOW ASSAYS MARKET FOR OTHER CARDIAC MARKER TESTING, BY REGION, 2023–2030 (USD MILLION) 173   TABLE 158 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR OTHER CARDIAC MARKER TESTING, BY COUNTRY, 2023–2030 (USD MILLION) 173 TABLE 159 EUROPE: LATERAL FLOW ASSAYS MARKET FOR OTHER CARDIAC MARKER TESTING, BY COUNTRY, 2023–2030 (USD MILLION) 174 TABLE 160 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR OTHER CARDIAC MARKER TESTING, BY COUNTRY, 2023–2030 (USD MILLION) 174 TABLE 161 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR OTHER CARDIAC MARKER TESTING, BY COUNTRY, 2023–2030 (USD MILLION) 175 TABLE 162 LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2023–2030 (USD MILLION) 176 TABLE 163 LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY REGION, 2023–2030 (USD MILLION) 176 TABLE 164 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY COUNTRY, 2023–2030 (USD MILLION) 176 TABLE 165 EUROPE: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY COUNTRY, 2023–2030 (USD MILLION) 177 TABLE 166 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY COUNTRY, 2023–2030 (USD MILLION) 177 TABLE 167 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY COUNTRY, 2023–2030 (USD MILLION) 178 TABLE 168 KEY PREGNANCY TESTING PRODUCTS AVAILABLE WORLDWIDE 179 TABLE 169 LATERAL FLOW ASSAYS MARKET FOR PREGNANCY TESTING, BY REGION, 2023–2030 (USD MILLION) 179 TABLE 170 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY TESTING, BY COUNTRY, 2023–2030 (USD MILLION) 180 TABLE 171 EUROPE: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY TESTING, BY COUNTRY, 2023–2030 (USD MILLION) 180 TABLE 172 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY TESTING, BY COUNTRY, 2023–2030 (USD MILLION) 180 TABLE 173 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY TESTING, BY COUNTRY, 2023–2030 (USD MILLION) 181 TABLE 174 LATERAL FLOW ASSAYS MARKET FOR FERTILITY TESTING, BY REGION, 2023–2030 (USD MILLION) 182 TABLE 175 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR FERTILITY TESTING, BY COUNTRY, 2023–2030 (USD MILLION) 182 TABLE 176 EUROPE: LATERAL FLOW ASSAYS MARKET FOR FERTILITY TESTING, BY COUNTRY, 2023–2030 (USD MILLION) 182 TABLE 177 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR FERTILITY TESTING, BY COUNTRY, 2023–2030 (USD MILLION) 183 TABLE 178 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR FERTILITY TESTING, BY COUNTRY, 2023–2030 (USD MILLION) 183 TABLE 179 KEY CHOLESTEROL TESTING PRODUCTS AVAILABLE WORLDWIDE 184 TABLE 180 LATERAL FLOW ASSAYS MARKET FOR CHOLESTEROL/LIPID TESTING, BY REGION, 2023–2030 (USD MILLION) 184 TABLE 181 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR CHOLESTEROL/LIPID TESTING, BY COUNTRY, 2023–2030 (USD MILLION) 185 TABLE 182 EUROPE: LATERAL FLOW ASSAYS MARKET FOR CHOLESTEROL/LIPID TESTING, BY COUNTRY, 2023–2030 (USD MILLION) 185   TABLE 183 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR CHOLESTEROL/LIPID TESTING, BY COUNTRY, 2023–2030 (USD MILLION) 186 TABLE 184 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR CHOLESTEROL/LIPID TESTING, BY COUNTRY, 2023–2030 (USD MILLION) 186 TABLE 185 LATERAL FLOW ASSAYS MARKET FOR DRUG-OF-ABUSE TESTING, BY REGION, 2023–2030 (USD MILLION) 187 TABLE 186 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR DRUG-OF-ABUSE TESTING, BY COUNTRY, 2023–2030 (USD MILLION) 187 TABLE 187 EUROPE: LATERAL FLOW ASSAYS MARKET FOR DRUG-OF-ABUSE TESTING, BY COUNTRY, 2023–2030 (USD MILLION) 188 TABLE 188 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR DRUG-OF-ABUSE TESTING, BY COUNTRY, 2023–2030 (USD MILLION) 188 TABLE 189 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR DRUG-OF-ABUSE TESTING, BY COUNTRY, 2023–2030 (USD MILLION) 189 TABLE 190 LATERAL FLOW ASSAYS MARKET FOR OTHER CLINICAL TESTS, BY REGION, 2023–2030 (USD MILLION) 190 TABLE 191 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR OTHER CLINICAL TESTS, BY COUNTRY, 2023–2030 (USD MILLION) 190 TABLE 192 EUROPE: LATERAL FLOW ASSAYS MARKET FOR OTHER CLINICAL TESTS, BY COUNTRY, 2023–2030 (USD MILLION) 190 TABLE 193 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR OTHER CLINICAL TESTS, BY COUNTRY, 2023–2030 (USD MILLION) 191 TABLE 194 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR OTHER CLINICAL TESTS, BY COUNTRY, 2023–2030 (USD MILLION) 191 TABLE 195 LATERAL FLOW ASSAYS MARKET FOR VETERINARY DIAGNOSTICS, BY REGION, 2023–2030 (USD MILLION) 192 TABLE 196 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR VETERINARY DIAGNOSTICS, BY COUNTRY, 2023–2030 (USD MILLION) 193 TABLE 197 EUROPE: LATERAL FLOW ASSAYS MARKET FOR VETERINARY DIAGNOSTICS, BY COUNTRY, 2023–2030 (USD MILLION) 193 TABLE 198 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR VETERINARY DIAGNOSTICS, BY COUNTRY, 2023–2030 (USD MILLION) 193 TABLE 199 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR VETERINARY DIAGNOSTICS, BY COUNTRY, 2023–2030 (USD MILLION) 194 TABLE 200 LATERAL FLOW ASSAYS MARKET FOR FOOD & ENVIRONMENT TESTING, BY REGION, 2023–2030 (USD MILLION) 195 TABLE 201 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR FOOD & ENVIRONMENT TESTING, BY COUNTRY, 2023–2030 (USD MILLION) 195 TABLE 202 EUROPE: LATERAL FLOW ASSAYS MARKET FOR FOOD & ENVIRONMENT TESTING, BY COUNTRY, 2023–2030 (USD MILLION) 195 TABLE 203 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR FOOD & ENVIRONMENT TESTING, BY COUNTRY, 2023–2030 (USD MILLION) 196 TABLE 204 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR FOOD & ENVIRONMENT TESTING, BY COUNTRY, 2023–2030 (USD MILLION) 196 TABLE 205 LATERAL FLOW ASSAYS MARKET FOR DRUG DEVELOPMENT & QUALITY TESTING, BY REGION, 2023–2030 (USD MILLION) 197 TABLE 206 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR DRUG DEVELOPMENT & QUALITY TESTING, BY COUNTRY, 2023–2030 (USD MILLION) 197 TABLE 207 EUROPE: LATERAL FLOW ASSAYS MARKET FOR DRUG DEVELOPMENT & QUALITY TESTING, BY COUNTRY, 2023–2030 (USD MILLION) 198   TABLE 208 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR DRUG DEVELOPMENT & QUALITY TESTING, BY COUNTRY, 2023–2030 (USD MILLION) 198 TABLE 209 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR DRUG DEVELOPMENT & QUALITY TESTING, BY COUNTRY, 2023–2030 (USD MILLION) 199 TABLE 210 LATERAL FLOW ASSAYS MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION) 201 TABLE 211 LATERAL FLOW ASSAYS MARKET FOR SANDWICH ASSAYS, BY REGION, 2023–2030 (USD MILLION) 202 TABLE 212 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR SANDWICH ASSAYS, BY COUNTRY, 2023–2030 (USD MILLION) 202 TABLE 213 EUROPE: LATERAL FLOW ASSAYS MARKET FOR SANDWICH ASSAYS, BY COUNTRY, 2023–2030 (USD MILLION) 203 TABLE 214 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR SANDWICH ASSAYS, BY COUNTRY, 2023–2030 (USD MILLION) 203 TABLE 215 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR SANDWICH ASSAYS, BY COUNTRY, 2023–2030 (USD MILLION) 204 TABLE 216 LATERAL FLOW ASSAYS MARKET FOR COMPETITIVE ASSAYS, BY REGION, 2023–2030 (USD MILLION) 205 TABLE 217 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR COMPETITIVE ASSAYS, BY COUNTRY, 2023–2030 (USD MILLION) 205 TABLE 218 EUROPE: LATERAL FLOW ASSAYS MARKET FOR COMPETITIVE ASSAYS, BY COUNTRY, 2023–2030 (USD MILLION) 205 TABLE 219 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR COMPETITIVE ASSAYS, BY COUNTRY, 2023–2030 (USD MILLION) 206 TABLE 220 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR COMPETITIVE ASSAYS, BY COUNTRY, 2023–2030 (USD MILLION) 206 TABLE 221 LATERAL FLOW ASSAYS MARKET FOR MULTIPLEX DETECTION ASSAYS, BY REGION, 2023–2030 (USD MILLION) 207 TABLE 222 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR MULTIPLEX DETECTION ASSAYS, BY COUNTRY, 2023–2030 (USD MILLION) 207 TABLE 223 EUROPE: LATERAL FLOW ASSAYS MARKET FOR MULTIPLEX DETECTION ASSAYS, BY COUNTRY, 2023–2030 (USD MILLION) 208 TABLE 224 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR MULTIPLEX DETECTION ASSAYS, BY COUNTRY, 2023–2030 (USD MILLION) 208 TABLE 225 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR MULTIPLEX DETECTION ASSAYS, BY COUNTRY, 2023–2030 (USD MILLION) 209 TABLE 226 LATERAL FLOW ASSAYS MARKET, BY SAMPLE TYPE, 2023–2030 (USD MILLION) 211 TABLE 227 LATERAL FLOW ASSAYS MARKET FOR BLOOD SAMPLES, BY REGION, 2023–2030 (USD MILLION) 212 TABLE 228 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR BLOOD SAMPLES, BY COUNTRY, 2023–2030 (USD MILLION) 212 TABLE 229 EUROPE: LATERAL FLOW ASSAYS MARKET FOR BLOOD SAMPLES, BY COUNTRY, 2023–2030 (USD MILLION) 212 TABLE 230 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR BLOOD SAMPLES, BY COUNTRY, 2023–2030 (USD MILLION) 213 TABLE 231 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR BLOOD SAMPLES, BY COUNTRY, 2023–2030 (USD MILLION) 213 TABLE 232 LATERAL FLOW ASSAYS MARKET FOR URINE SAMPLES, BY REGION, 2023–2030 (USD MILLION) 214   TABLE 233 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR URINE SAMPLES, BY COUNTRY, 2023–2030 (USD MILLION) 214 TABLE 234 EUROPE: LATERAL FLOW ASSAYS MARKET FOR URINE SAMPLES, BY COUNTRY, 2023–2030 (USD MILLION) 215 TABLE 235 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR URINE SAMPLES, BY COUNTRY, 2023–2030 (USD MILLION) 215 TABLE 236 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR URINE SAMPLES, BY COUNTRY, 2023–2030 (USD MILLION) 216 TABLE 237 LATERAL FLOW ASSAYS MARKET FOR SALIVA SAMPLES, BY REGION, 2023–2030 (USD MILLION) 216 TABLE 238 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR SALIVA SAMPLES, BY COUNTRY, 2023–2030 (USD MILLION) 217 TABLE 239 EUROPE: LATERAL FLOW ASSAYS MARKET FOR SALIVA SAMPLES, BY COUNTRY, 2023–2030 (USD MILLION) 217 TABLE 240 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR SALIVA SAMPLES, BY COUNTRY, 2023–2030 (USD MILLION) 217 TABLE 241 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR SALIVA SAMPLES, BY COUNTRY, 2023–2030 (USD MILLION) 218 TABLE 242 LATERAL FLOW ASSAYS MARKET FOR OTHER SAMPLES, BY REGION, 2023–2030 (USD MILLION) 219 TABLE 243 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR OTHER SAMPLES, BY COUNTRY, 2023–2030 (USD MILLION) 219 TABLE 244 EUROPE: LATERAL FLOW ASSAYS MARKET FOR OTHER SAMPLES, BY COUNTRY, 2023–2030 (USD MILLION) 219 TABLE 245 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR OTHER SAMPLES, BY COUNTRY, 2023–2030 (USD MILLION) 220 TABLE 246 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR OTHER SAMPLES, BY COUNTRY, 2023–2030 (USD MILLION) 220 TABLE 247 LATERAL FLOW ASSAYS MARKET, BY END USER, 2023–2030 (USD MILLION) 222 TABLE 248 LATERAL FLOW ASSAYS MARKET FOR HOSPITALS & CLINICS, BY REGION, 2023–2030 (USD MILLION) 223 TABLE 249 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2023–2030 (USD MILLION) 224 TABLE 250 EUROPE: LATERAL FLOW ASSAYS MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2023–2030 (USD MILLION) 224 TABLE 251 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2023–2030 (USD MILLION) 224 TABLE 252 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2023–2030 (USD MILLION) 225 TABLE 253 LATERAL FLOW ASSAYS MARKET FOR HOME CARE SETTINGS, BY REGION, 2023–2030 (USD MILLION) 226 TABLE 254 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2023–2030 (USD MILLION) 226 TABLE 255 EUROPE: LATERAL FLOW ASSAYS MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2023–2030 (USD MILLION) 226 TABLE 256 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2023–2030 (USD MILLION) 227 TABLE 257 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2023–2030 (USD MILLION) 227   TABLE 258 LATERAL FLOW ASSAYS MARKET FOR DIAGNOSTIC LABORATORIES, BY REGION, 2023–2030 (USD MILLION) 228 TABLE 259 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION) 228 TABLE 260 EUROPE: LATERAL FLOW ASSAYS MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION) 229 TABLE 261 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION) 229 TABLE 262 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION) 230 TABLE 263 LATERAL FLOW ASSAYS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2023–2030 (USD MILLION) 231 TABLE 264 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION) 231 TABLE 265 EUROPE: LATERAL FLOW ASSAYS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION) 231 TABLE 266 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION) 232 TABLE 267 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION) 232 TABLE 268 LATERAL FLOW ASSAYS MARKET FOR OTHER END USERS, BY REGION, 2023–2030 (USD MILLION) 233 TABLE 269 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2030 (USD MILLION) 233 TABLE 270 EUROPE: LATERAL FLOW ASSAYS MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2030 (USD MILLION) 234 TABLE 271 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2030 (USD MILLION) 234 TABLE 272 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2030 (USD MILLION) 235 TABLE 273 LATERAL FLOW ASSAYS MARKET, BY REGION, 2023–2030 (USD MILLION) 237 TABLE 274 NORTH AMERICA: MACROECONOMIC INDICATORS 238 TABLE 275 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 239 TABLE 276 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 240 TABLE 277 NORTH AMERICA: LATERAL FLOW READERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 240 TABLE 278 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 240 TABLE 279 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2023–2030 (USD MILLION) 241 TABLE 280 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2023–2030 (USD MILLION) 241 TABLE 281 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2023–2030 (USD MILLION) 242 TABLE 282 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2023–2030 (USD MILLION) 242   TABLE 283 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2023–2030 (USD MILLION) 243 TABLE 284 NORTH AMERICA: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION) 243 TABLE 285 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2023–2030 (USD MILLION) 243 TABLE 286 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET, BY END USER, 2023–2030 (USD MILLION) 244 TABLE 287 US: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 245 TABLE 288 US: LATERAL FLOW READERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 245 TABLE 289 US: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 245 TABLE 290 US: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2023–2030 (USD MILLION) 246 TABLE 291 US: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2023–2030 (USD MILLION) 246 TABLE 292 US: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2023–2030 (USD MILLION) 247 TABLE 293 US: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2023–2030 (USD MILLION) 247 TABLE 294 US: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2023–2030 (USD MILLION) 248 TABLE 295 US: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION) 248 TABLE 296 US: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2023–2030 (USD MILLION) 248 TABLE 297 US: LATERAL FLOW ASSAYS MARKET, BY END USER, 2023–2030 (USD MILLION) 249 TABLE 298 CANADA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 250 TABLE 299 CANADA: LATERAL FLOW READERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 250 TABLE 300 CANADA: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 250 TABLE 301 CANADA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2023–2030 (USD MILLION) 251 TABLE 302 CANADA: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2023–2030 (USD MILLION) 251 TABLE 303 CANADA: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2023–2030 (USD MILLION) 252 TABLE 304 CANADA: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2023–2030 (USD MILLION) 252 TABLE 305 CANADA: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2023–2030 (USD MILLION) 253 TABLE 306 CANADA: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION) 253 TABLE 307 CANADA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2023–2030 (USD MILLION) 253 TABLE 308 CANADA: LATERAL FLOW ASSAYS MARKET, BY END USER, 2023–2030 (USD MILLION) 254   TABLE 309 EUROPE: MACROECONOMIC INDICATORS 254 TABLE 310 EUROPE: LATERAL FLOW ASSAYS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 255 TABLE 311 EUROPE: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 255 TABLE 312 EUROPE: LATERAL FLOW READERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 255 TABLE 313 EUROPE: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 256 TABLE 314 EUROPE: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2023–2030 (USD MILLION) 256 TABLE 315 EUROPE: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2023–2030 (USD MILLION) 257 TABLE 316 EUROPE: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2023–2030 (USD MILLION) 257 TABLE 317 EUROPE: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2023–2030 (USD MILLION) 258 TABLE 318 EUROPE: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2023–2030 (USD MILLION) 258 TABLE 319 EUROPE: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION) 258 TABLE 320 EUROPE: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2023–2030 (USD MILLION) 259 TABLE 321 EUROPE: LATERAL FLOW ASSAYS MARKET, BY END USER, 2023–2030 (USD MILLION) 259 TABLE 322 GERMANY: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 260 TABLE 323 GERMANY: LATERAL FLOW READERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 260 TABLE 324 GERMANY: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 261 TABLE 325 GERMANY: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2023–2030 (USD MILLION) 261 TABLE 326 GERMANY: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2023–2030 (USD MILLION) 262 TABLE 327 GERMANY: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2023–2030 (USD MILLION) 262 TABLE 328 GERMANY: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2023–2030 (USD MILLION) 263 TABLE 329 GERMANY: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2023–2030 (USD MILLION) 263 TABLE 330 GERMANY: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION) 263 TABLE 331 GERMANY: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2023–2030 (USD MILLION) 264 TABLE 332 GERMANY: LATERAL FLOW ASSAYS MARKET, BY END USER, 2023–2030 (USD MILLION) 264 TABLE 333 UK: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 265 TABLE 334 UK: LATERAL FLOW READERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 265 TABLE 335 UK: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 265 TABLE 336 UK: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2023–2030 (USD MILLION) 266 TABLE 337 UK: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2023–2030 (USD MILLION) 266 TABLE 338 UK: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2023–2030 (USD MILLION) 267 TABLE 339 UK: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2023–2030 (USD MILLION) 267 TABLE 340 UK: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2023–2030 (USD MILLION) 268 TABLE 341 UK: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION) 268 TABLE 342 UK: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2023–2030 (USD MILLION) 268 TABLE 343 UK: LATERAL FLOW ASSAYS MARKET, BY END USER, 2023–2030 (USD MILLION) 269 TABLE 344 FRANCE: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 270 TABLE 345 FRANCE: LATERAL FLOW READERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 270 TABLE 346 FRANCE: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 270 TABLE 347 FRANCE: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2023–2030 (USD MILLION) 271 TABLE 348 FRANCE: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2023–2030 (USD MILLION) 271 TABLE 349 FRANCE: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2023–2030 (USD MILLION) 272 TABLE 350 FRANCE: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2023–2030 (USD MILLION) 272 TABLE 351 FRANCE: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2023–2030 (USD MILLION) 273 TABLE 352 FRANCE: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION) 273 TABLE 353 FRANCE: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2023–2030 (USD MILLION) 273 TABLE 354 FRANCE: LATERAL FLOW ASSAYS MARKET, BY END USER, 2023–2030 (USD MILLION) 274 TABLE 355 ITALY: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 274 TABLE 356 ITALY: LATERAL FLOW READERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 275 TABLE 357 ITALY: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 275 TABLE 358 ITALY: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2023–2030 (USD MILLION) 275 TABLE 359 ITALY: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2023–2030 (USD MILLION) 276 TABLE 360 ITALY: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2023–2030 (USD MILLION) 276 TABLE 361 ITALY: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2023–2030 (USD MILLION) 277   TABLE 362 ITALY: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2023–2030 (USD MILLION) 277 TABLE 363 ITALY: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION) 277 TABLE 364 ITALY: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2023–2030 (USD MILLION) 278 TABLE 365 ITALY: LATERAL FLOW ASSAYS MARKET, BY END USER, 2023–2030 (USD MILLION) 278 TABLE 366 SPAIN: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 279 TABLE 367 SPAIN: LATERAL FLOW READERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 279 TABLE 368 SPAIN: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 279 TABLE 369 SPAIN: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2023–2030 (USD MILLION) 280 TABLE 370 SPAIN: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2023–2030 (USD MILLION) 280 TABLE 371 SPAIN: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2023–2030 (USD MILLION) 281 TABLE 372 SPAIN: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2023–2030 (USD MILLION) 281 TABLE 373 SPAIN: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2023–2030 (USD MILLION) 282 TABLE 374 SPAIN: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION) 282 TABLE 375 SPAIN: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2023–2030 (USD MILLION) 282 TABLE 376 SPAIN: LATERAL FLOW ASSAYS MARKET, BY END USER, 2023–2030 (USD MILLION) 283 TABLE 377 REST OF EUROPE: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 283 TABLE 378 REST OF EUROPE: LATERAL FLOW READERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 284 TABLE 379 REST OF EUROPE: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 284 TABLE 380 REST OF EUROPE: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2023–2030 (USD MILLION) 284 TABLE 381 REST OF EUROPE: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2023–2030 (USD MILLION) 285 TABLE 382 REST OF EUROPE: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2023–2030 (USD MILLION) 285 TABLE 383 REST OF EUROPE: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2023–2030 (USD MILLION) 286 TABLE 384 REST OF EUROPE: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2023–2030 (USD MILLION) 286 TABLE 385 REST OF EUROPE: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION) 286 TABLE 386 REST OF EUROPE: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2023–2030 (USD MILLION) 287   TABLE 387 REST OF EUROPE: LATERAL FLOW ASSAYS MARKET, BY END USER, 2023–2030 (USD MILLION) 287 TABLE 388 ASIA PACIFIC: KEY MACROECONOMIC INDICATORS 288 TABLE 389 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 290 TABLE 390 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 290 TABLE 391 ASIA PACIFIC: LATERAL FLOW READERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 290 TABLE 392 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 291 TABLE 393 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2023–2030 (USD MILLION) 291 TABLE 394 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2023–2030 (USD MILLION) 292 TABLE 395 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2023–2030 (USD MILLION) 292 TABLE 396 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2023–2030 (USD MILLION) 293 TABLE 397 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2023–2030 (USD MILLION) 293 TABLE 398 ASIA PACIFIC: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION) 293 TABLE 399 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2023–2030 (USD MILLION) 294 TABLE 400 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET, BY END USER, 2023–2030 (USD MILLION) 294 TABLE 401 JAPAN: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 295 TABLE 402 JAPAN: LATERAL FLOW READERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 295 TABLE 403 JAPAN: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 296 TABLE 404 JAPAN: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2023–2030 (USD MILLION) 296 TABLE 405 JAPAN: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2023–2030 (USD MILLION) 297 TABLE 406 JAPAN: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2023–2030 (USD MILLION) 297 TABLE 407 JAPAN: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2023–2030 (USD MILLION) 298 TABLE 408 JAPAN: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2023–2030 (USD MILLION) 298 TABLE 409 JAPAN: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION) 298 TABLE 410 JAPAN: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2023–2030 (USD MILLION) 299 TABLE 411 JAPAN: LATERAL FLOW ASSAYS MARKET, BY END USER, 2023–2030 (USD MILLION) 299 TABLE 412 CHINA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 300   TABLE 413 CHINA: LATERAL FLOW READERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 300 TABLE 414 CHINA: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 301 TABLE 415 CHINA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2023–2030 (USD MILLION) 301 TABLE 416 CHINA: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2023–2030 (USD MILLION) 302 TABLE 417 CHINA: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2023–2030 (USD MILLION) 302 TABLE 418 CHINA: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2023–2030 (USD MILLION) 303 TABLE 419 CHINA: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2023–2030 (USD MILLION) 303 TABLE 420 CHINA: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION) 303 TABLE 421 CHINA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2023–2030 (USD MILLION) 304 TABLE 422 CHINA: LATERAL FLOW ASSAYS MARKET, BY END USER, 2023–2030 (USD MILLION) 304 TABLE 423 INDIA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 305 TABLE 424 INDIA: LATERAL FLOW READERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 305 TABLE 425 INDIA: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 305 TABLE 426 INDIA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2023–2030 (USD MILLION) 306 TABLE 427 INDIA: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2023–2030 (USD MILLION) 306 TABLE 428 INDIA: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2023–2030 (USD MILLION) 307 TABLE 429 INDIA: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2023–2030 (USD MILLION) 307 TABLE 430 INDIA: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2023–2030 (USD MILLION) 308 TABLE 431 INDIA: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION) 308 TABLE 432 INDIA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2023–2030 (USD MILLION) 308 TABLE 433 INDIA: LATERAL FLOW ASSAYS MARKET, BY END USER, 2023–2030 (USD MILLION) 309 TABLE 434 AUSTRALIA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 310 TABLE 435 AUSTRALIA: LATERAL FLOW READERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 310 TABLE 436 AUSTRALIA: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 310 TABLE 437 AUSTRALIA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2023–2030 (USD MILLION) 311 TABLE 438 AUSTRALIA: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2023–2030 (USD MILLION) 311   TABLE 439 AUSTRALIA: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2023–2030 (USD MILLION) 312 TABLE 440 AUSTRALIA: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2023–2030 (USD MILLION) 312 TABLE 441 AUSTRALIA: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2023–2030 (USD MILLION) 313 TABLE 442 AUSTRALIA: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION) 313 TABLE 443 AUSTRALIA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2023–2030 (USD MILLION) 313 TABLE 444 AUSTRALIA: LATERAL FLOW ASSAYS MARKET, BY END USER, 2023–2030 (USD MILLION) 314 TABLE 445 SOUTH KOREA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 315 TABLE 446 SOUTH KOREA: LATERAL FLOW READERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 315 TABLE 447 SOUTH KOREA: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 315 TABLE 448 SOUTH KOREA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2023–2030 (USD MILLION) 316 TABLE 449 SOUTH KOREA: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2023–2030 (USD MILLION) 316 TABLE 450 SOUTH KOREA: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2023–2030 (USD MILLION) 317 TABLE 451 SOUTH KOREA: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2023–2030 (USD MILLION) 317 TABLE 452 SOUTH KOREA: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2023–2030 (USD MILLION) 318 TABLE 453 SOUTH KOREA: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION) 318 TABLE 454 SOUTH KOREA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2023–2030 (USD MILLION) 318 TABLE 455 SOUTH KOREA: LATERAL FLOW ASSAYS MARKET, BY END USER, 2023–2030 (USD MILLION) 319 TABLE 456 REST OF ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 320 TABLE 457 REST OF ASIA PACIFIC: LATERAL FLOW READERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 320 TABLE 458 REST OF ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 320 TABLE 459 REST OF ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2023–2030 (USD MILLION) 321 TABLE 460 REST OF ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2023–2030 (USD MILLION) 321 TABLE 461 REST OF ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2023–2030 (USD MILLION) 322 TABLE 462 REST OF ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2023–2030 (USD MILLION) 322 TABLE 463 REST OF ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2023–2030 (USD MILLION) 323   TABLE 464 REST OF ASIA PACIFIC: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION) 323 TABLE 465 REST OF ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2023–2030 (USD MILLION) 323 TABLE 466 REST OF ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET, BY END USER, 2023–2030 (USD MILLION) 324 TABLE 467 LATIN AMERICA: KEY MACROECONOMIC INDICATORS 324 TABLE 468 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 325 TABLE 469 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 325 TABLE 470 LATIN AMERICA: LATERAL FLOW READERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 325 TABLE 471 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 326 TABLE 472 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2023–2030 (USD MILLION) 326 TABLE 473 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2023–2030 (USD MILLION) 327 TABLE 474 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2023–2030 (USD MILLION) 327 TABLE 475 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2023–2030 (USD MILLION) 328 TABLE 476 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2023–2030 (USD MILLION) 328 TABLE 477 LATIN AMERICA: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION) 328 TABLE 478 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2023–2030 (USD MILLION) 329 TABLE 479 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET, BY END USER, 2023–2030 (USD MILLION) 329 TABLE 480 BRAZIL: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 330 TABLE 481 BRAZIL: LATERAL FLOW READERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 330 TABLE 482 BRAZIL: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 330 TABLE 483 BRAZIL: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2023–2030 (USD MILLION) 331 TABLE 484 BRAZIL: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2023–2030 (USD MILLION) 331 TABLE 485 BRAZIL: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2023–2030 (USD MILLION) 332 TABLE 486 BRAZIL: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2023–2030 (USD MILLION) 332 TABLE 487 BRAZIL: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2023–2030 (USD MILLION) 333 TABLE 488 BRAZIL: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION) 333   TABLE 489 BRAZIL: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2023–2030 (USD MILLION) 333 TABLE 490 BRAZIL: LATERAL FLOW ASSAYS MARKET, BY END USER, 2023–2030 (USD MILLION) 334 TABLE 491 MEXICO: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 335 TABLE 492 MEXICO: LATERAL FLOW READERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 335 TABLE 493 MEXICO: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 335 TABLE 494 MEXICO: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2023–2030 (USD MILLION) 336 TABLE 495 MEXICO: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2023–2030 (USD MILLION) 336 TABLE 496 MEXICO: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2023–2030 (USD MILLION) 337 TABLE 497 MEXICO: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2023–2030 (USD MILLION) 337 TABLE 498 MEXICO: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2023–2030 (USD MILLION) 338 TABLE 499 MEXICO: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION) 338 TABLE 500 MEXICO: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2023–2030 (USD MILLION) 338 TABLE 501 MEXICO: LATERAL FLOW ASSAYS MARKET, BY END USER, 2023–2030 (USD MILLION) 339 TABLE 502 ARGENTINA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 339 TABLE 503 ARGENTINA: LATERAL FLOW READERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 340 TABLE 504 ARGENTINA: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 340 TABLE 505 ARGENTINA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2023–2030 (USD MILLION) 340 TABLE 506 ARGENTINA: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2023–2030 (USD MILLION) 341 TABLE 507 ARGENTINA: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2023–2030 (USD MILLION) 341 TABLE 508 ARGENTINA: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2023–2030 (USD MILLION) 342 TABLE 509 ARGENTINA: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2023–2030 (USD MILLION) 342 TABLE 510 ARGENTINA: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION) 342 TABLE 511 ARGENTINA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2023–2030 (USD MILLION) 343 TABLE 512 ARGENTINA: LATERAL FLOW ASSAYS MARKET, BY END USER, 2023–2030 (USD MILLION) 343 TABLE 513 REST OF LATIN AMERICA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 344   TABLE 514 REST OF LATIN AMERICA: LATERAL FLOW READERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 344 TABLE 515 REST OF LATIN AMERICA: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 344 TABLE 516 REST OF LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2023–2030 (USD MILLION) 345 TABLE 517 REST OF LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2023–2030 (USD MILLION) 345 TABLE 518 REST OF LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2023–2030 (USD MILLION) 346 TABLE 519 REST OF LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2023–2030 (USD MILLION) 346 TABLE 520 REST OF LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2023–2030 (USD MILLION) 347 TABLE 521 REST OF LATIN AMERICA: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION) 347 TABLE 522 REST OF LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2023–2030 (USD MILLION) 347 TABLE 523 REST OF LATIN AMERICA: LATERAL FLOW ASSAYS MARKET, BY END USER, 2023–2030 (USD MILLION) 348 TABLE 524 MIDDLE EAST & AFRICA: KEY MACROECONOMIC INDICATORS 349 TABLE 525 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 349 TABLE 526 MIDDLE EAST & AFRICA: LATERAL FLOW READERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 349 TABLE 527 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 350 TABLE 528 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2023–2030 (USD MILLION) 350 TABLE 529 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2023–2030 (USD MILLION) 351 TABLE 530 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2023–2030 (USD MILLION) 351 TABLE 531 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2023–2030 (USD MILLION) 352 TABLE 532 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2023–2030 (USD MILLION) 352 TABLE 533 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION) 352 TABLE 534 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2023–2030 (USD MILLION) 353 TABLE 535 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAYS MARKET, BY END USER, 2023–2030 (USD MILLION) 353 TABLE 536 GCC COUNTRIES: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 354 TABLE 537 GCC COUNTRIES: LATERAL FLOW READERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 354 TABLE 538 GCC COUNTRIES: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 355   TABLE 539 GCC COUNTRIES: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2023–2030 (USD MILLION) 355 TABLE 540 GCC COUNTRIES: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2023–2030 (USD MILLION) 356 TABLE 541 GCC COUNTRIES: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2023–2030 (USD MILLION) 356 TABLE 542 GCC COUNTRIES: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2023–2030 (USD MILLION) 357 TABLE 543 GCC COUNTRIES: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2023–2030 (USD MILLION) 357 TABLE 544 GCC COUNTRIES: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION) 357 TABLE 545 GCC COUNTRIES: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2023–2030 (USD MILLION) 358 TABLE 546 GCC COUNTRIES: LATERAL FLOW ASSAYS MARKET, BY END USER, 2023–2030 (USD MILLION) 358 TABLE 547 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN LATERAL FLOW ASSAYS MARKET 360 TABLE 548 LATERAL FLOW ASSAYS MARKET: DEGREE OF COMPETITION 363 TABLE 549 LATERAL FLOW ASSAYS MARKET: REGIONAL FOOTPRINT, 2024 369 TABLE 550 LATERAL FLOW ASSAYS MARKET: PRODUCT FOOTPRINT, 2024 370 TABLE 551 LATERAL FLOW ASSAYS MARKET: TECHNIQUE FOOTPRINT. 2024 371 TABLE 552 LATERAL FLOW ASSAYS MARKET: APPLICATION FOOTPRINT, 2024 372 TABLE 553 LATERAL FLOW ASSAYS MARKET: SAMPLE TYPE FOOTPRINT, 2024 373 TABLE 554 LATERAL FLOW ASSAYS MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS, 2024 375 TABLE 555 LATERAL FLOW ASSAYS MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES, 2024 375 TABLE 556 LATERAL FLOW ASSAYS MARKET: PRODUCT LAUNCHES, JANUARY 2021–MAY 2025 376 TABLE 557 LATERAL FLOW ASSAYS MARKET: DEALS, JANUARY 2021–MAY 2025 376 TABLE 558 LATERAL FLOW ASSAYS MARKET: EXPANSIONS, JANUARY 2021–MAY 2025 377 TABLE 559 ABBOTT LABORATORIES: BUSINESS OVERVIEW 378 TABLE 560 ABBOTT LABORATORIES: PRODUCTS OFFERED 379 TABLE 561 ABBOTT LABORATORIES: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–MAY 2025 383 TABLE 562 F. HOFFMANN-LA ROCHE LTD.: COMPANY OVERVIEW 384 TABLE 563 F. HOFFMANN-LA ROCHE LTD.: PRODUCTS OFFERED 385 TABLE 564 DANAHER CORPORATION: COMPANY OVERVIEW 387 TABLE 565 DANAHER CORPORATION: PRODUCTS OFFERED 388 TABLE 566 QUIDELORTHOORTHO CORPORATION: COMPANY OVERVIEW 390 TABLE 567 QUIDELORTHOORTHO CORPORATION: PRODUCTS OFFERED 391 TABLE 568 QUIDELORTHOORTHO CORPORATION: DEALS 392 TABLE 569 SIEMENS AG: COMPANY OVERVIEW 393 TABLE 570 SIEMENS AG: PRODUCTS OFFERED 395   TABLE 571 BECTON, DICKINSON AND COMPANY: COMPANY OVERVIEW 396 TABLE 572 BECTON, DICKINSON AND COMPANY: PRODUCTS OFFERED 398 TABLE 573 BIOMÉRIEUX SA: COMPANY OVERVIEW 399 TABLE 574 BIOMÉRIEUX SA: PRODUCTS OFFERED 400 TABLE 575 BIOMÉRIEUX SA: DEALS 401 TABLE 576 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW 402 TABLE 577 THERMO FISHER SCIENTIFIC INC.: PRODUCTS OFFERED 403 TABLE 578 REVVITY, INC.: COMPANY OVERVIEW 405 TABLE 579 REVVITY, INC.: PRODUCTS OFFERED 406 TABLE 580 QIAGEN N.V.: COMPANY OVERVIEW 407 TABLE 581 QIAGEN N.V.: PRODUCTS OFFERED 408 TABLE 582 MERCK KGAA: COMPANY OVERVIEW 409 TABLE 583 MERCK KGAA: PRODUCTS OFFERED 410 TABLE 584 MERCK KGAA: EXPANSIONS 410 TABLE 585 HOLOGIC, INC.: COMPANY OVERVIEW 411 TABLE 586 HOLOGIC, INC.: PRODUCTS OFFERED 412 TABLE 587 HOLOGIC, INC.: DEALS 413 TABLE 588 SURMODICS, INC.: COMPANY OVERVIEW 414 TABLE 589 SURMODICS, INC.: PRODUCTS OFFERED 416 TABLE 590 SURMODICS, INC.: DEALS 416 TABLE 591 ORASURE TECHNOLOGIES: COMPANY OVERVIEW 417 TABLE 592 ORASURE TECHNOLOGIES: PRODUCTS OFFERED 418 TABLE 593 CHEMBIO DIAGNOSTICS INC.: COMPANY OVERVIEW 419 TABLE 594 DCN DIAGNOSTICS: COMPANY OVERVIEW 420 TABLE 595 POLYSCIENCES INC.: COMPANY OVERVIEW 421 TABLE 596 ABINGDON HEALTH: COMPANY OVERVIEW 422 TABLE 597 ORANOXIS INC.: COMPANY OVERVIEW 423 TABLE 598 AESKU.GROUP GMBH: COMPANY OVERVIEW 424 TABLE 599 BIO GROUP MEDICAL SYSTEM S.R.L: COMPANY OVERVIEW 425 TABLE 600 PHARMACT GMBH: COMPANY OVERVIEW 426 TABLE 601 XIAMEN BIOTIME BIOTECHNOLOGY CO., LTD.: COMPANY OVERVIEW 427 TABLE 602 BIOPANDA REAGENTS LTD: COMPANY OVERVIEW 428 TABLE 603 ARTRON LABORATORIES INC.: COMPANY OVERVIEW 429 FIGURE 1 LATERAL FLOW ASSAYS: MARKET SEGMENTATION 43 FIGURE 2 STUDY YEARS CONSIDERED 44 FIGURE 3 LATERAL FLOW ASSAYS MARKET: RESEARCH DESIGN 46 FIGURE 4 KEY DATA FROM SECONDARY SOURCES 47 FIGURE 5 LIST OF PRIMARY SOURCES 48 FIGURE 6 KEY INSIGHTS FROM INDUSTRY EXPERTS 49 FIGURE 7 BREAKDOWN OF PRIMARY INTERVIEWS, BY COMPANY TYPE, DESIGNATION, AND REGION 50 FIGURE 8 BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH 52 FIGURE 9 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 53 FIGURE 10 LATERAL FLOW ASSAYS MARKET: TOP-DOWN APPROACH 53 FIGURE 11 DATA TRIANGULATION METHODOLOGY 54 FIGURE 12 LATERAL FLOW ASSAYS MARKET: ASSUMPTION IMPACT ASSESSMENT 55 FIGURE 13 LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2025 VS. 2030 (USD BILLION) 57 FIGURE 14 LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2025 VS. 2030 (USD MILLION) 58 FIGURE 15 LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2025 VS. 2030 (USD MILLION) 58 FIGURE 16 LATERAL FLOW ASSAY MARKET, BY SAMPLE TYPE, 2025 VS. 2030 (USD MILLION) 59 FIGURE 17 LATERAL FLOW ASSAYS MARKET, BY END USER, 2025 VS. 2030 (USD MILLION) 59 FIGURE 18 GEOGRAPHICAL SNAPSHOT OF LATERAL FLOW ASSAYS MARKET 60 FIGURE 19 HIGH PREVALENCE OF INFECTIOUS DISEASES TO DRIVE MARKET 62 FIGURE 20 CLINICAL TESTING APPLICATION AND CHINA LED ASIA PACIFIC MARKET IN 2024 63 FIGURE 21 CHINA TO RECORD HIGHEST GROWTH RATE FROM 2025 TO 2030 64 FIGURE 22 ASIA PACIFIC TO WITNESS HIGHEST GROWTH DURING FORECAST PERIOD 64 FIGURE 23 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH DURING FORECAST PERIOD 65 FIGURE 24 LATERAL FLOW ASSAYS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 66 FIGURE 25 LATERAL FLOW ASSAYS MARKET: PORTER’S FIVE FORCES ANALYSIS 74 FIGURE 26 LATERAL FLOW ASSAYS MARKET: PATENT ANALYSIS, JANUARY 2015–DECEMBER 2024 81 FIGURE 27 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE APPLICATIONS 87 FIGURE 28 KEY BUYING CRITERIA FOR TOP THREE APPLICATIONS 88 FIGURE 29 VALUE CHAIN ANALYSIS: MAJOR VALUE-ADDED DURING MANUFACTURING AND ASSEMBLY PHASES 89 FIGURE 30 LATERAL FLOW ASSAYS MARKET: SUPPLY CHAIN ANALYSIS 90 FIGURE 31 AI USE CASES 92 FIGURE 32 LATERAL FLOW ASSAYS MARKET: ECOSYSTEM ANALYSIS 93 FIGURE 33 ADJACENT MARKETS FOR LATERAL FLOW ASSAYS MARKET 96 FIGURE 34 LATERAL FLOW ASSAYS MARKET: TRENDS AND DISRUPTIONS IMPACTING CUSTOMER BUSINESS 96   FIGURE 35 LATERAL FLOW ASSAYS MARKET: INVESTMENT AND FUNDING SCENARIO, 2020–2024 97 FIGURE 36 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET SNAPSHOT 239 FIGURE 37 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET SNAPSHOT 289 FIGURE 38 REVENUE ANALYSIS OF KEY PLAYERS IN LATERAL FLOW ASSAYS MARKET, 2020–2024 361 FIGURE 39 MARKET SHARE ANALYSIS OF KEY PLAYERS IN LATERAL FLOW ASSAYS MARKET, 2024 362 FIGURE 40 EV/EBITDA OF KEY VENDORS, 2025 364 FIGURE 41 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS, 2025 364 FIGURE 42 LATERAL FLOW ASSAYS MARKET: BRAND/PRODUCT COMPARISON 365 FIGURE 43 LATERAL FLOW ASSAYS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024 367 FIGURE 44 LATERAL FLOW ASSAYS MARKET: COMPANY FOOTPRINT, 2024 368 FIGURE 45 LATERAL FLOW ASSAYS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024 374 FIGURE 46 ABBOTT LABORATORIES: COMPANY SNAPSHOT, 2024 379 FIGURE 47 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT, 2024 385 FIGURE 48 DANAHER CORPORATION: COMPANY SNAPSHOT, 2024 388 FIGURE 49 QUIDELORTHOORTHO CORPORATION: COMPANY SNAPSHOT, 2024 391 FIGURE 50 SIEMENS AG: COMPANY SNAPSHOT, 2024 394 FIGURE 51 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT, 2024 397 FIGURE 52 BIOMÉRIEUX SA: COMPANY SNAPSHOT, 2024 400 FIGURE 53 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT, 2024 403 FIGURE 54 REVVITY, INC.: COMPANY SNAPSHOT, 2024 405 FIGURE 55 QIAGEN N.V.: COMPANY SNAPSHOT, 2024 408 FIGURE 56 MERCK KGAA: COMPANY SNAPSHOT, 2024 409 FIGURE 57 HOLOGIC, INC.: COMPANY SNAPSHOT, 2024 412 FIGURE 58 SURMODICS, INC.: COMPANY SNAPSHOT, 2024 415 FIGURE 59 ORASURE TECHNOLOGIES: COMPANY SNAPSHOT, 2024 417

同分類最新報告（醫療器材）

查看醫療器材全部報告 →

量子訊息有限公司為 MarketsandMarkets 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們